Promising new Australian cancer drug licensed to U.S pharmaceutical company

​A promising new Australian cancer drug has been licensed to a U.S pharmaceutical company in the hope that it might contribute to a reduction in the cancer mortality rate.

Xinhua News Agency

Xinhua News Agency

9 Years ago

South Pacific Peat CTx drug protein cancer